481 related articles for article (PubMed ID: 24396149)
1. Mechanisms of protein-folding diseases at a glance.
Valastyan JS; Lindquist S
Dis Model Mech; 2014 Jan; 7(1):9-14. PubMed ID: 24396149
[TBL] [Abstract][Full Text] [Related]
2. Screening methods for identifying pharmacological chaperones.
Shin MH; Lim HS
Mol Biosyst; 2017 Mar; 13(4):638-647. PubMed ID: 28265599
[TBL] [Abstract][Full Text] [Related]
3. Emergent properties of proteostasis in managing cystic fibrosis.
Balch WE; Roth DM; Hutt DM
Cold Spring Harb Perspect Biol; 2011 Feb; 3(2):. PubMed ID: 21421917
[TBL] [Abstract][Full Text] [Related]
4. Protein misfolding in disease and small molecule therapies.
Gomes CM
Curr Top Med Chem; 2012; 12(22):2460-9. PubMed ID: 23339300
[TBL] [Abstract][Full Text] [Related]
5. The threads that tie protein-folding diseases.
Brodsky JL
Dis Model Mech; 2014 Jan; 7(1):3-4. PubMed ID: 24396147
[TBL] [Abstract][Full Text] [Related]
6. Molecular chaperone functions in protein folding and proteostasis.
Kim YE; Hipp MS; Bracher A; Hayer-Hartl M; Hartl FU
Annu Rev Biochem; 2013; 82():323-55. PubMed ID: 23746257
[TBL] [Abstract][Full Text] [Related]
7. Therapy through chaperones: sense or antisense? Cystic fibrosis as a model disease.
Amaral MD
J Inherit Metab Dis; 2006; 29(2-3):477-87. PubMed ID: 16763920
[TBL] [Abstract][Full Text] [Related]
8. Roles of extracellular chaperones in amyloidosis.
Wyatt AR; Yerbury JJ; Dabbs RA; Wilson MR
J Mol Biol; 2012 Aug; 421(4-5):499-516. PubMed ID: 22248589
[TBL] [Abstract][Full Text] [Related]
9. The role of the cytosolic HSP70 chaperone system in diseases caused by misfolding and aberrant trafficking of ion channels.
Young JC
Dis Model Mech; 2014 Mar; 7(3):319-29. PubMed ID: 24609033
[TBL] [Abstract][Full Text] [Related]
10. Human heat shock protein 105/110 kDa (Hsp105/110) regulates biogenesis and quality control of misfolded cystic fibrosis transmembrane conductance regulator at multiple levels.
Saxena A; Banasavadi-Siddegowda YK; Fan Y; Bhattacharya S; Roy G; Giovannucci DR; Frizzell RA; Wang X
J Biol Chem; 2012 Jun; 287(23):19158-70. PubMed ID: 22505710
[TBL] [Abstract][Full Text] [Related]
11. The chaperone Grp78 in protein folding disorders of the nervous system.
Moreno JA; Tiffany-Castiglioni E
Neurochem Res; 2015 Feb; 40(2):329-35. PubMed ID: 25107299
[TBL] [Abstract][Full Text] [Related]
12. Protein-misfolding diseases and chaperone-based therapeutic approaches.
Chaudhuri TK; Paul S
FEBS J; 2006 Apr; 273(7):1331-49. PubMed ID: 16689923
[TBL] [Abstract][Full Text] [Related]
13. Biological and structural basis for Aha1 regulation of Hsp90 ATPase activity in maintaining proteostasis in the human disease cystic fibrosis.
Koulov AV; LaPointe P; Lu B; Razvi A; Coppinger J; Dong MQ; Matteson J; Laister R; Arrowsmith C; Yates JR; Balch WE
Mol Biol Cell; 2010 Mar; 21(6):871-84. PubMed ID: 20089831
[TBL] [Abstract][Full Text] [Related]
14. Underlying mechanisms and chemical/biochemical therapeutic approaches to ameliorate protein misfolding neurodegenerative diseases.
Hekmatimoghaddam S; Zare-Khormizi MR; Pourrajab F
Biofactors; 2017 Nov; 43(6):737-759. PubMed ID: 26899445
[TBL] [Abstract][Full Text] [Related]
15. Extracellular chaperones and proteostasis.
Wyatt AR; Yerbury JJ; Ecroyd H; Wilson MR
Annu Rev Biochem; 2013; 82():295-322. PubMed ID: 23350744
[TBL] [Abstract][Full Text] [Related]
16. Pharmacoperone drugs: targeting misfolded proteins causing lysosomal storage-, ion channels-, and G protein-coupled receptors-associated conformational disorders.
Hou ZS; Ulloa-Aguirre A; Tao YX
Expert Rev Clin Pharmacol; 2018 Jun; 11(6):611-624. PubMed ID: 29851355
[TBL] [Abstract][Full Text] [Related]
17. Protein Misfolding Diseases and Therapeutic Approaches.
Yadav K; Yadav A; Vashistha P; Pandey VP; Dwivedi UN
Curr Protein Pept Sci; 2019; 20(12):1226-1245. PubMed ID: 31187709
[TBL] [Abstract][Full Text] [Related]
18. The Nucleolus as a Proteostasis Regulator.
Amer-Sarsour F; Ashkenazi A
Trends Cell Biol; 2019 Nov; 29(11):849-851. PubMed ID: 31473054
[TBL] [Abstract][Full Text] [Related]
19. Hsp90 cochaperone Aha1 downregulation rescues misfolding of CFTR in cystic fibrosis.
Wang X; Venable J; LaPointe P; Hutt DM; Koulov AV; Coppinger J; Gurkan C; Kellner W; Matteson J; Plutner H; Riordan JR; Kelly JW; Yates JR; Balch WE
Cell; 2006 Nov; 127(4):803-15. PubMed ID: 17110338
[TBL] [Abstract][Full Text] [Related]
20. Protein Misfolding Diseases.
Hartl FU
Annu Rev Biochem; 2017 Jun; 86():21-26. PubMed ID: 28441058
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
